From Late-Stage Development To Launch: A Predictive Approach To Complex OSD Challenges

As oral solid dosage (OSD) products become more complex, development teams face growing challenges around limited API availability, formulation complexity, scale-up risk, and compressed timelines. A predictive, data-driven development strategy offers a way to address these pressures by connecting material attributes, process parameters, and product quality early in development.

Technologies such as advanced material characterization, Quality by Design (QbD), Design of Experiments (DoE), and in silico modeling help generate deeper process understanding while reducing unnecessary experimentation and conserving valuable API. By identifying potential issues before they affect validation or commercial manufacturing, companies can establish more robust processes, improve scalability, and accelerate development with greater confidence. Real-world results demonstrate how predictive tools can resolve manufacturing challenges, reduce material consumption, and support successful validation.

For organizations developing increasingly sophisticated OSD products, integrating predictive modeling with scientific expertise can help transform complexity into a more efficient, reliable path from late-stage development to commercial launch.